Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis

dc.contributor.authorElseragy Amr
dc.contributor.authorBello Ibrahim O.
dc.contributor.authorWahab Awais
dc.contributor.authorColetta Ricardo D.
dc.contributor.authorMäkitie Antti A.
dc.contributor.authorLeivo Ilmo
dc.contributor.authorAlmangush Alhadi
dc.contributor.authorSalo Tuula
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id175203739
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/175203739
dc.date.accessioned2022-10-28T14:04:54Z
dc.date.available2022-10-28T14:04:54Z
dc.description.abstract<p>Although there are many histopathologic prognosticators, grading of early oral tongue squamous cell carcinoma (OTSCC) is still based on morphological cell differentiation which has low prognostic value. Here we summarize the emerging histopathological markers showing powerful prognostic value, but are not included in pathology reports. Using PubMed, Scopus, Ovid Medline, and Web of Science databases, a systematic literature search was preformed to identify early OTSCC studies that investigated the prognostic significance of hematoxylin-eosin-based histopathologic markers. Our meta-analysis showed that tumor budding was associated with overall survival (hazard ratio [HR] 2.32; 95% CI 1.40-3.84; p < 0.01) and disease-specific survival (DSS) (1.89; 95% CI 1.13-3.15; p = 0.02). Worst pattern of invasion was associated with disease-free survival (DFS) (1.95; 95% CI 1.04-3.64; p = 0.04). Tumor-stroma ratio was also associated with DFS (1.75, 95% CI 1.24-2.48; p < 0.01) and DSS (1.69; 95% CI 1.19-2.42; p < 0.01). Tumor budding, worst pattern of invasion, and tumor-stroma ratio have a promising prognostic value in early OTSCC. The evaluation and reporting of these markers is cost-effective and can be incorporated in daily practice.</p>
dc.format.pagerange1491
dc.identifier.eissn1097-0347
dc.identifier.jour-issn1043-3074
dc.identifier.olddbid186150
dc.identifier.oldhandle10024/169244
dc.identifier.urihttps://www.utupub.fi/handle/11111/31256
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/10.1002/hed.27022
dc.identifier.urnURN:NBN:fi-fe2022081154812
dc.language.isoen
dc.okm.affiliatedauthorLeivo, Ilmo
dc.okm.affiliatedauthorAlmangush, Alhadi
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3125 Otorhinolaryngology, ophthalmologyen_GB
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherWILEY
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1002/hed.27022
dc.relation.ispartofjournalHead and Neck
dc.relation.issue6
dc.relation.volume44
dc.source.identifierhttps://www.utupub.fi/handle/10024/169244
dc.titleEmerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis
dc.year.issued2022

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
LeivoEtAl2022EmergingHistopathologicMarkers.pdf
Size:
5.64 MB
Format:
Adobe Portable Document Format